Request a Consultation Patient Portal (opens in a new tab) Pay Bill (opens in a new tab)
AQ Surgery
(561) 834-6788

Early Detection and Prevention

Identifying precancerous lesions and analyzing the underlying genetic markers offers new possibilities in the early treatment and potential eradication of cancers before they progress to a more serious stage. AQ Surgery is at the forefront of utilizing innovative technologies like Proteocyte AI to provide patients with the most advanced care possible. Proteocyte AI is a state-of-the-art gene analysis platform designed to assess precancerous lesions, helping doctors and patients make informed decisions about treatment and preventive strategies. By incorporating this breakthrough technology, Dr. Anastasiya Quimby allows her patients to catch cancer early, even before it can develop, ensuring a proactive and personalized approach to care.

What Is Proteocyte AI?

Precancerous lesions are abnormal growths or changes in cells; although not all progress to cancer, some can eventually develop into malignant tumors if left untreated. By analyzing specific genetic markers and alterations and providing a deeper understanding of the genetic factors at play, Proteocyte AI can help stratify the risk of progression by determining the likelihood that a lesion will develop into cancer.  The technology evaluates the expression of certain genes known to be involved in cancer development.

These genes may be linked to cell growth, DNA repair, immune response, or other biological processes that transform normal cells into cancerous ones. By identifying patterns in gene expression, West Palm Beach precancer lesions gene analysis can generate a risk score that helps Dr. Quimby determine whether a lesion requires immediate intervention or can be monitored over time.

Banner media
woman in yellow shirt smiling

What to Expect During the Process

The process begins with collecting a tissue sample from the precancerous lesion, which is then analyzed for specific genetic markers. The tissue is processed in the lab, and its genetic material is extracted. The genes of interest are then analyzed to detect any mutations, alterations, or patterns in their expression that are linked to cancer progression. Proteocyte AI uses advanced algorithms to compare the genetic data from the tissue sample to a large database of known cancer markers. Based on this analysis, the platform generates a risk score that reflects the likelihood of the lesion becoming cancerous. With the risk score in hand, Dr. Quimby can develop a personalized treatment plan for each patient. For those with high-risk lesions, early intervention, such as surgical removal or targeted therapy, may be recommended. For lower-risk lesions, regular monitoring and follow-up visits may be sufficient.

Benefits of Proteocyte AI in Precancerous Lesion Management

Early Detection

Proteocyte AI enables the identification of genetic changes associated with cancer development before they manifest as visible tumors. This allows for early intervention, potentially preventing the lesion from progressing to cancer.

Personalized Care

By analyzing a lesion's unique genetic makeup, Proteocyte AI provides personalized insights into the patient’s cancer risk. This allows Dr. Quimby to tailor her treatment recommendations to each patient's specific needs.

Minimized Unnecessary Interventions

Not all precancerous lesions require aggressive treatment. Proteocyte AI helps distinguish between high-risk and low-risk lesions, ensuring patients receive the appropriate level of care without unnecessary surgeries or therapies.

Improved Treatment Outcomes

For patients with high-risk lesions, early intervention guided by genetic analysis can lead to better outcomes. By catching cancer before it fully develops, doctors can offer more effective treatments with a higher chance of success.

Reduced Anxiety for Patients

Waiting for test results and wondering whether a lesion will become cancerous can be stressful for patients. Proteocyte AI provides clear, data-driven insights into the likelihood of progression, giving patients peace of mind and a clearer understanding of their condition.

Background media

Who Is a Candidate for Proteocyte AI?

Patients with a history of precancerous lesions or those who are at higher risk of developing cancer may particularly benefit from Proteocyte AI analysis. This includes individuals with the following:

  • Oral leukoplakia: A white patch in the mouth that can develop into oral cancer if left untreated.
  • Actinic keratosis: A rough, scaly patch on the skin caused by sun exposure, which can progress to skin cancer.
  • Barrett’s esophagus: A condition where the lining of the esophagus changes due to chronic acid reflux, increasing the risk of esophageal cancer.
  • Cervical dysplasia: Abnormal cell growth in the cervix, which can lead to cervical cancer.
  • Atypical moles: Unusual moles that may be at risk of turning into melanoma, a dangerous form of skin cancer.

Schedule a Consultation

Contact Us
Contact us media

Why Choose AQ Surgery?

Dr. Anastasiya Quimby, board-certified surgeon and founder of AQ Surgery, is committed to providing her patients with the highest level of care through cutting-edge technology and personalized treatment plans. Her expertise in oral and maxillofacial surgery, head and neck oncology, and microvascular reconstruction, combined with the use of Proteocyte AI, ensures that her patients receive accurate diagnoses and effective care tailored to their individual needs.

By incorporating Proteocyte AI into her practice, Dr. Quimby empowers her patients with knowledge, allowing them to take control of their health and make informed decisions about their care. Whether you are at risk of developing cancer or already have a precancerous lesion, Proteocyte AI offers a powerful tool for early detection and prevention.

Take Charge of Your Health at AQ Surgery

Precancerous lesions can be unpredictable, but with the help of Proteocyte AI, patients have access to advanced gene analysis that can significantly improve the chances of early detection and successful treatment. AQ Surgery uses this innovative technology to provide our patients with the best possible outcomes, ensuring your care is personalized, proactive, and focused on long-term health. If you are concerned about precancerous lesions or want to learn more about how West Palm Beach precancer gene analysis can help you, contact AQ Surgery today to schedule a consultation.

Background media

Schedule a Consultation

A Comprehensive, Patient-Centered Approach

Contact Us
Contact us media
Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at (561) 834-6788.
Contact Us